Search research articles
Contact Us
Filters
Showing results (261-270 of 277) with videos related to
Page
of 28
Sort By:
BMJ Open
|
March 29, 2024
Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study
Soumaya Labidi, Nicholas Meti, Reeta Barua, et al.
Cell Death & Disease
|
May 6, 2026
mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway
Feiyang Cai, Fan Huang, Christophe Goncalves, et al.
Environmental Pollution (Barking, Essex : 1987)
|
April 5, 2011
Open Air Laboratories (OPAL): a community-driven research programme
L Davies, J N B Bell, J Bone, et al.
Cancers
|
July 24, 2021
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
Deirdre Kelly, April A N Rose, Thiago Pimentel Muniz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2018
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas
Matthew Dankner, Mathieu Lajoie, Dan Moldoveanu, et al.
JCO Precision Oncology
|
January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers
Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
NMR in Biomedicine
|
January 18, 2022
Development of a cardiovascular magnetic resonance-compatible large animal isolated heart model for direct comparison of beating and arrested hearts
Andrew D Scott, Tim Jackson, Zohya Khalique, et al.
Science Advances
|
September 7, 2022
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER<sup>+</sup> breast cancer with mitotic aberrations
Isabel Soria-Bretones, Kelsie L Thu, Jennifer Silvester, et al.
Breast (Edinburgh, Scotland)
|
May 8, 2023
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases
Anna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, et al.
Molecular Cancer Therapeutics
|
February 1, 2023
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 277) with videos related to
Sort By:
Page
of 28
BMJ Open
|
March 29, 2024
Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study
Soumaya Labidi, Nicholas Meti, Reeta Barua, et al.
Cell Death & Disease
|
May 6, 2026
mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway
Feiyang Cai, Fan Huang, Christophe Goncalves, et al.
Environmental Pollution (Barking, Essex : 1987)
|
April 5, 2011
Open Air Laboratories (OPAL): a community-driven research programme
L Davies, J N B Bell, J Bone, et al.
Cancers
|
July 24, 2021
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
Deirdre Kelly, April A N Rose, Thiago Pimentel Muniz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2018
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas
Matthew Dankner, Mathieu Lajoie, Dan Moldoveanu, et al.
JCO Precision Oncology
|
January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers
Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
NMR in Biomedicine
|
January 18, 2022
Development of a cardiovascular magnetic resonance-compatible large animal isolated heart model for direct comparison of beating and arrested hearts
Andrew D Scott, Tim Jackson, Zohya Khalique, et al.
Science Advances
|
September 7, 2022
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER<sup>+</sup> breast cancer with mitotic aberrations
Isabel Soria-Bretones, Kelsie L Thu, Jennifer Silvester, et al.
Breast (Edinburgh, Scotland)
|
May 8, 2023
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases
Anna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, et al.
Molecular Cancer Therapeutics
|
February 1, 2023
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, et al.
Page
of 28